NATCAPSUQBSENATURAL CAPSULES LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 2 Sept, 2026 · 11:18 IST

Board approves revised preferential issue terms to promoter at 178 rupees

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+8.5%Reaction day
₹200.00
prior close
₹206.07
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+9.1% vs market
Pharmaceuticals peers, median of 171sector-0.2%+8.7% vs sector

On the reaction day the stock moved 9.1 pts more than Nifty Microcap 250 and 8.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-0.8
15m
-0.8
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+8.5-0.6+9.1-0.2+8.7
Next day
+13.5+0.0+13.5+0.2+13.3
2d
+10.2+0.7+9.5+0.1+10.1
3d
+2.8+1.1+1.7+0.6+2.2
4d
-2.1+1.6-3.7+0.8-2.9
5d
-2.0+1.5-3.5+0.1-2.1
1w
-5.7+1.4-7.0+0.6-6.2
15d
-14.4+0.4-14.8+0.8-15.2
1m
-17.5-1.4-16.1-2.0-15.5
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natural Capsules board revised price and quantity of its preferential issue to promoter Sunil L. Mundra. It covers 1,12,500 equity shares at 178 rupees and 4,50,000 convertible warrants at 178 rupees, aggregating about 10 crores rupees. Promoter stake will rise from 5.79 percent to 10.61 percent post full conversion. 25 percent upfront for warrants, balance on conversion within 18 months. EGM on September 9, 2026.

Likely market impact

Promoter stake rises from 5.79 to 10.61 percent, signaling confidence. Causes dilution for existing shareholders. Watch EGM outcome on September 9.